RANSOMWARE VICTIMHEALTHCAREDUPLICATE CLAIM

Nang Kuang Pharmaceutical Co., Ltd.

INCRANSOM📍 TW (TW)📅 February 15, 2026
8
same group

Attack Intelligence

Nang Kuang Pharmaceutical Co., Ltd. was compromised in a ransomware attack attributed to INCRANSOM in February 2026. The organization, operating in the Healthcare sector in TW, was added to the group's data leak site as part of an extortion campaign.

INCRANSOM operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

Nang Kuang Pharmaceutical Co. Ltd Revenue: 70M$ Nang Kuang Pharmaceutical Co. Ltd, nangkuang.com.tw , Total data in the leak: 430GB Leaked data: - Clients and Parners: Rosetta, PeptiStar Inc, Shiratori Pharmaceutical Co Ltd, Apexcela co. ltd, Somerset Pharma LLC., CureLeads FZ-LLC., Pfizer and other companies worldwide - Data Classification: confidential / Secret - Projects: Eroxon, Cinacalcet, Icatibant, Exparel, bupivacaine and many other medical drugs Data: Agreements, projects, lawsuits from Pfizer, clinical reports from inception to late phase, Personal info (ID scans), emails data, CDA and NDA, Clinical Review, Product Risk Assessment, RGD, RDO, DMF, GMP, CRF And a lot of other VERY IMPORTANT information! Full publication within four weeks!

Additional Details

Other Victims — INCRANSOM (8)

Quick Facts

CountryTW (TW)
SectorHealthcare
Attack DateFeb 15, 2026
Intel Sourceransomware.live
StatusDUPLICATE CLAIM

Threat Group

INCRANSOM
Motivation: financial
View group profile →

External Links

Data sourced from Ransomware.live, RansomLook, and CTIWATCH OSINT collection. Victim listing does not imply confirmed breach — intelligence based on group claims.